Laboratory data
| Variable . | Reference range . | On presentation, referring hospital (day 1) . | On presentation, our hospital (day 16) . |
|---|---|---|---|
| WBC count (×103/μL) | 4.0-9.0 | 18.2 | 3.9 |
| Hemoglobin (g/dL) | 11.5-15.0 | 6.3 | 10.5 |
| Platelet count (×104/mm3) | 15.0-35.0 | 10.0 | 37.6 |
| PT (s) | 10-13 | 16.5 | 10.2 |
| APTT (s) | 26-40 | >150 | 26.3 |
| Fibrinogen (g/dL) | 160-400 | <40 | 284 |
| Antithrombin III (%) | 80-130 | 68.5 | 68.5 |
| FDP (μg/mL) | 0-5.0 | 152.9 | 115 |
| D-dimer (μg/mL) | 0-1.0 | 47.6 | 45.9 |
| Soluble fibrin monomer complex (FU/mL) | <6.1 | — | >250 |
| Antiplasmin (%) | 80-120 | — | 63 |
| PIC (μg/mL) | <5.0 | — | 21.6 |
| TAT (μg/mL) | 0-3.0 | — | 36.8 |
| PC activity (%) | 70-140 | — | 123 |
| Protein S activity (%) | 65-140 | — | 164 |
| sTM (FU/mL) | 1.8-3.9 | — | >32 |
| Variable . | Reference range . | On presentation, referring hospital (day 1) . | On presentation, our hospital (day 16) . |
|---|---|---|---|
| WBC count (×103/μL) | 4.0-9.0 | 18.2 | 3.9 |
| Hemoglobin (g/dL) | 11.5-15.0 | 6.3 | 10.5 |
| Platelet count (×104/mm3) | 15.0-35.0 | 10.0 | 37.6 |
| PT (s) | 10-13 | 16.5 | 10.2 |
| APTT (s) | 26-40 | >150 | 26.3 |
| Fibrinogen (g/dL) | 160-400 | <40 | 284 |
| Antithrombin III (%) | 80-130 | 68.5 | 68.5 |
| FDP (μg/mL) | 0-5.0 | 152.9 | 115 |
| D-dimer (μg/mL) | 0-1.0 | 47.6 | 45.9 |
| Soluble fibrin monomer complex (FU/mL) | <6.1 | — | >250 |
| Antiplasmin (%) | 80-120 | — | 63 |
| PIC (μg/mL) | <5.0 | — | 21.6 |
| TAT (μg/mL) | 0-3.0 | — | 36.8 |
| PC activity (%) | 70-140 | — | 123 |
| Protein S activity (%) | 65-140 | — | 164 |
| sTM (FU/mL) | 1.8-3.9 | — | >32 |
APTT, activated partial thromboplastin time; PIC, plasmin inhibitor complex; PT, prothrombin.